欧州の耳鼻咽喉科機器市場：製品タイプ別、エンドユーザー別、国別 - 分析と予測（2024年～2033年）

欧州の耳鼻咽喉科機器の市場規模は、2024年に52億4,000万米ドなりました。

同市場は、2033年には87億5,000万米ドルに達し、予測期間の2024年～2033年のCAGRは5.86%になると予測されています。耳鼻咽喉（ENT）疾患の診断、治療、管理に使用される医療機器は、欧州の耳鼻咽喉科機器市場で広く流通しています。耳鼻咽喉科疾患の頻度の増加と低侵襲処置のニーズの高まりが、市場の急拡大を後押ししています。デジタル補聴器、人工内耳、内視鏡は、患者の予後を改善し、耳鼻咽喉科専門医の診療範囲を拡大する技術革新の一例です。

耳鼻咽喉科疾患の有病率の上昇、臨床研究や臨床試験の拡大、効率的な耳鼻咽喉科機器へのニーズの高まりは、市場拡大の要因の一部です。また、低侵襲治療の普及に伴い、より効果的なソリューションを提供する新しい機器が開発されています。

市場の拡大は、人口の高齢化や政府の取り組みにも大きく影響されています。小売店やインターネット・プラットフォームなど、さまざまな流通チャネルを通じて耳鼻咽喉科機器が入手しやすくなっていることも、市場の成長と欧州全域の顧客へのアクセスをさらに刺激しています。洗練された患者中心のソリューションに対するニーズが高まる限り、市場は今後も革新と発展を続けると予想されます。

低侵襲手術に対する需要の高まりと耳鼻咽喉（ENT）疾患の罹患率の上昇が、欧州の耳鼻咽喉科機器市場を牽引しています。睡眠時無呼吸症候群、副鼻腔炎、難聴など、さまざまな耳鼻咽喉科疾患の診断、治療、患者の転帰を改善する技術が進歩しています。例えば、デジタル補聴器、人工内耳、内視鏡機器などです。

耳鼻咽喉科機器の改良を目的とした研究や臨床試験の増加に加え、耳鼻咽喉科疾患の有病率の上昇により、市場は拡大しています。低侵襲手術の普及に伴い、より効果的で効率的な医療機器の開発が進んでいます。

市場の拡大を後押ししている2つの主な要因は、人口の高齢化と最先端治療を奨励する政府のヘルスケア・プログラムです。さらに、オンライン・プラットフォームや小売店など、さまざまな流通チャネルを通じて製品へのアクセスが増加したことで、欧州全域の患者にとってのアクセシビリティが向上しています。ヘルスケアシステムが進化を続ける中、先進的な耳鼻咽喉科機器の需要は今後も伸び続けると予想され、イノベーションの促進と患者ケアの向上につながります。

当レポートでは、欧州の耳鼻咽喉科機器市場について調査し、市場の概要とともに、製品タイプ別、エンドユーザー別、国別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

第1章 市場

• 業界見通し
• COVID-19別耳鼻咽喉科機器市場への影響
• 市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会

第2章 地域

• 地域別概要
• 欧州

第3章 市場-競合ベンチマーキングと企業プロファイル

• 競合情勢
  • 主要戦略と開発
  • パートナーシップ、提携、事業拡大
  • 新しいサービス
  • 合併と買収
  • 規制および法的活動
• 企業プロファイル
  • Ambu A/S
  • Demant A/S
  • BEBIG Medical GmbH
  • KARL STORZ SE & Co, KG
  • Medtronic plc
  • Richard Wolf GmbH
  • Smith and Nephew plc
  • Sonova Holding AG

第4章 調査手法

List of Figures

• Figure 1: ENT Devices Market (by Region), $Million, 2023, 2027, and 2033
• Figure 2: Europe ENT Devices Market (by Product), $Million, 2023 and 2033
• Figure 3: Key Events to Keep Track of in the ENT Devices Market
• Figure 4: Number of ENT Devices Patents (by Country), January 2020-June 2024
• Figure 5: Number of ENT Devices Patents (by Year), January 2020-June 2024
• Figure 6: Impact Analysis of Market Navigating Factors, 2023-2033
• Figure 7: Global Population Aged 85 years and Above, Million, 2010-2022
• Figure 8: Germany ENT Devices Market, $Million, 2023-2033
• Figure 9: U.K. ENT Devices Market, $Million, 2023-2033
• Figure 10: France ENT Devices Market, $Million, 2023-2033
• Figure 11: Italy ENT Devices Market, $Million, 2023-2033
• Figure 12: Rest-of-Europe ENT Devices Market, $Million, 2023-2033
• Figure 13: Share of Strategic Initiatives, 2021-2024
• Figure 14: Strategic Initiatives (by Year), January 2021- July 2024
• Figure 15: Partnerships, Alliances, and Business Expansions, January 2021-July 2024
• Figure 16: New Offerings, January 2021-July 2024
• Figure 17: Mergers and Acquisitions, January 2021-July 2024
• Figure 18: Regulatory and Legal, January 2021-July 2024
• Figure 19: Data Triangulation
• Figure 20: Top-Down and Bottom-Up Approach
• Figure 21: Assumptions and Limitations

List of Tables

• Table 1: Europe ENT Devices Market Snapshot
• Table 2: Opportunities across Regions
• Table 3: Europe ENT Devices Market, Inclusion Criteria
• Table 4: Europe ENT Devices Market, Exclusion Criteria
• Table 5: Key Trends, ENT Devices Market
• Table 6: ENT Devices Market, Regulatory Approvals and New Offerings
• Table 7: Europe ENT Devices Market Regulatory Framework
• Table 8: Rest-of-the-World ENT Devices Market Regulatory Framework
• Table 9: Recent Ongoing Clinical Trials in ENT Devices Market
• Table 10: Global Prevalence of Hearing Loss, 2019-2021
• Table 11: Prices of ENT Procedures
• Table 12: ENT Devices Market (by Region), $Million, 2023-2033
• Table 13: Europe ENT Devices Market (by Product Type), $Million, 2023-2033
• Table 14: Europe ENT Devices Market, Diagnostic Devices (by End User), $Million, 2023-2033
• Table 15: Europe ENT Devices Market, Surgical Devices (by End User), $Million, 2023-2033
• Table 16: Germany ENT Devices Market (by Product Type), $Million, 2023-2033
• Table 17: Germany ENT Devices Market, Diagnostic Devices (by End User), $Million, 2023-2033
• Table 18: Germany ENT Devices Market, Surgical Devices (by End User), $Million, 2023-2033
• Table 19: U.K. ENT Devices Market (by Product Type), $Million, 2023-2033
• Table 20: U.K. ENT Devices Market, Diagnostic Devices (by End User), $Million, 2023-2033
• Table 21: U.K. ENT Devices Market, Surgical Devices (by End User), $Million, 2023-2033
• Table 22: France ENT Devices Market (by Product Type), $Million, 2023-2033
• Table 23: France ENT Devices Market, Diagnostic Devices (by End User), $Million, 2023-2033
• Table 24: France ENT Devices Market, Surgical Devices (by End User), $Million, 2023-2033
• Table 25: Italy ENT Devices Market (by Product Type), $Million, 2023-2033
• Table 26: Italy ENT Devices Market, Diagnostic Devices (by End User), $Million, 2023-2033
• Table 27: Italy ENT Devices Market, Surgical Devices (by End User), $Million, 2023-2033
• Table 28: Rest-of-Europe ENT Devices Market (by Product Type), $Million, 2023-2033
• Table 29: Rest-of-Europe ENT Devices Market, Diagnostic Devices (by End User), $Million, 2023-2033
• Table 30: Rest-of-Europe ENT Devices Market, Surgical Devices (by End User), $Million, 2023-2033

Introduction to Europe ENT Devices Market

The Europe ENT devices market was valued at $5.24 billion in 2024 and is expected to reach $8.75 billion by 2033, growing at a CAGR of 5.86% during the forecast period 2024-2033. The medical equipment used to diagnose, treat, and manage ear, nose, and throat (ENT) disorders is widely distributed in the European ENT Devices Market. The increasing frequency of ENT disorders and the growing need for minimally invasive procedures are driving the market's rapid expansion. Digital hearing aids, cochlear implants, and endoscopes are examples of technological innovations that are improving patient outcomes and expanding the scope of practice for ENT specialists.

The growing prevalence of ENT disorders, the expansion of clinical research and trials, and the growing need for efficient ENT devices are some of the factors driving the market's expansion. Additionally, new devices that provide more effective solutions have been developed as a result of the growing popularity of minimally invasive treatments.

Market expansion is also significantly influenced by aging populations and government initiatives. The market's growth and accessibility to customers throughout Europe have been further stimulated by the growing availability of ENT devices through a variety of distribution channels, such as retail stores and internet platforms. It is anticipated that the market will continue to innovate and develop as long as there is a growing need for sophisticated, patient-centered solutions.

Market Introduction

The growing demand for minimally invasive procedures and the rising incidence of ear, nose, and throat (ENT) disorders are driving the market for ENT devices in Europe. Technology is advancing to improve diagnosis, treatment, and patient outcomes for a variety of ENT conditions, including sleep apnea, sinusitis, and hearing loss. Examples of these include digital hearing aids, cochlear implants, and endoscopic instruments.

In addition to increased research and clinical trials aimed at improving ENT devices, the market is growing as a result of the rising prevalence of ENT disorders. More effective and efficient medical devices are being developed as a result of the growing popularity of minimally invasive surgical techniques.

Two major factors propelling market expansion are the aging population and government healthcare programs that encourage cutting-edge therapies. Additionally, increased product accessibility via a range of distribution channels, such as online platforms and retail stores, is improving accessibility for patients across Europe. As healthcare systems continue to evolve, the demand for advanced ENT devices is expected to continue growing, fostering innovation and improving patient care.

Market Segmentation:

Segmentation 1: by Product Type

• Diagnostic Devices
• Surgical Devices
• Hearing Aids
• Visualization Devices
• Consumables
• Others

Segmentation 2: by End User (Surgical Devices)

• Hospitals
• Ambulatory Centers
• ENT Specialty Clinics

Segmentation 3: by End User (Diagnostic Devices)

• Hospitals
• Ambulatory Centers
• ENT Speciality Clinics
• Others

Segmentation 4: by Country

• Germany
• U.K.
• France
• Italy
• Rest-of-Europe

How can this report add value to an organization?

Product/Innovation Strategy: The Europe ENT devices market has been segmented based on product type and end user. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Competitive Strategy: The Europe ENT devices market is a highly fragmented market, with many smaller and private companies constantly entering the market. Key players in the Europe ENT devices market analyzed and profiled in the study involve established players that offer various kinds of products and services.

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

• Ambu A/S
• Demant A/S
• BEBIG Medical GmbH
• KARL STORZ SE & Co, KG
• Medtronic plc
• Richard Wolf GmbH
• Smith and Nephew plc
• Sonova Holding AG

Table of Contents

Executive Summary

Scope and Definition

1 Markets

• 1.1 Industry Outlook
  • 1.1.1 Trends: Current and Future Impact Assessment
    • 1.1.1.1 Miniaturization of Sensors and Components in Hearing Aids and Implants
    • 1.1.1.2 Increasing Product Approval by Regulatory Authorities Leading to Various New Offerings in the Market
  • 1.1.2 Patent Analysis
    • 1.1.2.1 Patent Filing Trend (by Country)
    • 1.1.2.2 Patent Filing Trend (by Year)
  • 1.1.3 Regulatory Landscape
  • 1.1.4 Supply Chain Analysis
  • 1.1.5 Ongoing Clinical Trial Studies
• 1.2 Impact of COVID-19 on ENT Devices Market
• 1.3 Market Dynamics
  • 1.3.1 Market Drivers
    • 1.3.1.1 Upsurge in Prevalence of Hearing Disorders
    • 1.3.1.2 Growing Geriatric Population Leading to Increased Demand for ENT Devices
    • 1.3.1.3 Growing Preference for Minimally Invasive Procedures in ENT Specialty
  • 1.3.2 Market Restraints
    • 1.3.2.1 High Cost of ENT Procedure
    • 1.3.2.2 Social Stigma Associated with Hearing Disorder
  • 1.3.3 Market Opportunities
    • 1.3.3.1 Increasing Demand for Cosmetic ENT Procedures

2 Region

• 2.1 Regional Summary
• 2.2 Europe
  • 2.2.1 Regional Overview
  • 2.2.2 Factors Driving the Market Growth
  • 2.2.3 Factors Impeding/Limiting the Market Growth
  • 2.2.4 By Product Type
  • 2.2.5 By End User
  • 2.2.6 Germany
    • 2.2.6.1 By Product Type
    • 2.2.6.2 By End User
  • 2.2.7 U.K.
    • 2.2.7.1 By Product Type
    • 2.2.7.2 By End User
  • 2.2.8 France
    • 2.2.8.1 By Product Type
    • 2.2.8.2 By End User
  • 2.2.9 Italy
    • 2.2.9.1 By Product Type
    • 2.2.9.2 By End User
  • 2.2.10 Rest-of-Europe
    • 2.2.10.1 By Product Type
    • 2.2.10.2 By End User

3 Markets - Competitive Benchmarking & Company Profiles

• 3.1 Competitive Landscape
  • 3.1.1 Key Strategies and Development
  • 3.1.2 Partnerships, Alliances, and Business Expansions
  • 3.1.3 New Offerings
  • 3.1.4 Mergers and Acquisitions
  • 3.1.5 Regulatory and Legal Activities
• 3.2 Company Profiles
  • 3.2.1 Ambu A/S
    • 3.2.1.1 Overview
    • 3.2.1.2 Top Products
    • 3.2.1.3 Top Competitors
    • 3.2.1.4 Target Customers/End Users
    • 3.2.1.5 Analyst View
  • 3.2.2 Demant A/S
    • 3.2.2.1 Overview
    • 3.2.2.2 Top Products/Product Portfolio
    • 3.2.2.3 Top Competitors
    • 3.2.2.4 Target Customers/End Users
    • 3.2.2.5 Analyst View
  • 3.2.3 BEBIG Medical GmbH
    • 3.2.3.1 Overview
    • 3.2.3.2 Top Products
    • 3.2.3.3 Target Customers/End Users
    • 3.2.3.4 Analyst View
  • 3.2.4 KARL STORZ SE & Co, KG
    • 3.2.4.1 Overview
    • 3.2.4.2 Top Products/Product Portfolio
    • 3.2.4.3 Top Competitors
    • 3.2.4.4 Target Customers/End Users
    • 3.2.4.5 Analyst View
  • 3.2.5 Medtronic plc
    • 3.2.5.1 Overview
    • 3.2.5.2 Top Products/Product Portfolio
    • 3.2.5.3 Top Competitors
    • 3.2.5.4 Target Customers/End Users
    • 3.2.5.5 Analyst View
  • 3.2.6 Richard Wolf GmbH
    • 3.2.6.1 Overview
    • 3.2.6.2 Top Products/Product Portfolio
    • 3.2.6.3 Top Competitors
    • 3.2.6.4 Target Customers/End Users
    • 3.2.6.5 Analyst View
  • 3.2.7 Smith and Nephew plc
    • 3.2.7.1 Overview
    • 3.2.7.2 Top Products/Product Portfolio
    • 3.2.7.3 Top Competitors
    • 3.2.7.4 Target Customers/End Users
    • 3.2.7.5 Analyst View
  • 3.2.8 Sonova Holding AG
    • 3.2.8.1 Overview
    • 3.2.8.2 Top Products/Product Portfolio
    • 3.2.8.3 Top Competitors
    • 3.2.8.4 Target Customers/End Users
    • 3.2.8.5 Analyst View

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation
• 4.2 Market Estimation and Forecast